EZH2 and glioblastoma: We proceeded in our characterization of the role of H19 in glioblastoma cells by investigating if, by modulating H19, we would be able to affect EZH2 binding to promoters of genes known to be epigenetically regulated by PRC2-mediated trimethylation of H3K27 [30].